Diazepam effects on peritoneal macrophage activity and corticosterone serum levels in Balb/C mice

Life Sciences

Volumn 65, Issue 20, 1999, Pages 2157-2165

  Massoco, C O ^a   Palermo Neto, J ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Diazepam; Immune system; Macrophage H2O2 release; Macrophage phagocytosis; Macrophage spreading

Indexed keywords

CORTICOSTERONE; DIAZEPAM; HYDROGEN PEROXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DRUG BINDING SITE; DRUG EFFECT; DRUG MECHANISM; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PHAGOCYTOSIS;

ADMINISTRATION, ORAL; ANIMALS; ANTI-ANXIETY AGENTS; CELL MIGRATION INHIBITION; CELL MOVEMENT; CELLS, CULTURED; CORTICOSTERONE; DIAZEPAM; HYDROGEN PEROXIDE; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED BALB C; PHAGOCYTOSIS; TETRADECANOYLPHORBOL ACETATE;

ANIMALIA; MYCOBACTERIUM BOVIS BCG;

EID: 0033536567     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(99)00481-6     Document Type: Article

References (41)

1. J. Descotes, R. Tedone, J. and C. Evreux, Immun. Letters 5 41-3 (1982).
2. I. Ruiz, J. Offermanns and K. L. Lanctot and U. Busto, J. Clin. Pharmacol. 33 124-125 (1993).
3. F. Zavala, J. Haumont and Lenfant, Europ J. Phamarcol. 106 561 (1984).
4. V. Papadoulos, Endoc. Rev. 14.222-240 (1993).
5. M. Schlumpf, W. Lichtensteiger and H. Ramseir, Pharmacol. Toxicol. 73 355 (1993).
6. M. Schlumpf, R. Parmar, A. Schreiber, H. R. Ramsier, E. Bütikofer, H Abriel, M. Barth, T. Rhyner and W. Llichtensteiger, Devel. Pharmacol. Therap. 18 145-158(1992).
7. F. R. Silva and J. Palermo-Neto, Immunopharmacol. Immunotoxicol. (in press), 1998.
8. D. A. Righi, S. R. Pinheiro, J. L. Guerra and J. Palermo-Neto, Immunopharmacol. Immunotoxicol. (in press), 1999.
9. E. M. A. Ugaz, S. R. Pinheiro, J. L. Guerra and J. Palermo-Neto, Immunopharmacol. Immunotoxicol. (in press), 1999.
10. M. Mariano, Ver. Inst. Med. Trop. 37 1-16 (1995).
11. A. A. Schreiber, K. Frei, W. Lichtensteiger and M. Schlumpf, Experien. 48 365-379 (1992).
12. M. Schlumpf, R. Parmar, H. R. Ramseir and W. Lichtensteiger, Developmental Pharmacology and Therapeutics 15 78-185 (1990).
13. M. Rabinovith and M. J. De Stefano, Experiment. Cell Res. 77 323 (1973).
14. M. Rabinovith and M. J. De Stefano, Experiment. Cell Res. 79 423 (1973).
15. T. A. Passeti, M. S. Dissertation, Biomedical Institute, São Paulo (1993).
16. M Russo, H. C. Teixeira, M. C. G. Marcondes and J. A. M. Barbuto, Braz. J. Med. Biol. Res. 22 1271-1273 (1989).
17. E. Pike and D. Mizel, J. Immunol. Meth. 46 211-226 (1981).
18. W. Sutano and E. R. De Kloet, Endocrin. 121 1405-1511 (1987).
19. E. Albers, L. Yogev, R. B. Todd and B. D. Goldman, Am. J. Physiol. 248 434-438 (1985).
20. N. Johson, F. Leone, Engineering and Physical Science. John Wiley (Ed.), 241-244, New York (1974).
21. R. A. B. Ezekowitz, J. Austyn, P. D. Stahl and S. Gordon, Journal of Experimental Medicine 154 60-76, (1981).
22. L. F. B. P., Costa Rosa, D. A. Safi and R. Curi, J. Leuk. Biol. 56 10-14 (1994).
23. L. De Martino, C. Nazarro, A. Merone, S. Concilio and M. Galdiero, Immunopharmacol. Immunotoxicol. 17 551-564 (1995).
24. C. M. Grosskinsky, R. A. Ezekowitz, G. Berton, S. Gordon and B. A. Askonas, Infec. Immunol. 39 1080-1086 (1983).
25. M. Dannenberg, M. Ando and K. Shima, J. Immunol. 109 1109-1121 (1972).
26. V. Covelli, P. Decandia, M. Altamura and E. Jirillo, Immunopharma. Immunotoxicol. 11 701-714 (1989).
27. M. Finnerty, T. J. Marczynski, H. J. Amirault, M, Urbancic and B. R. Andersen, Immunopharmacol. 22 185-193 (1991).
28. P. L. Capecchi, L. Ceccatelli, U. Beermann, F. L. Passini and T. Di Perri, Arzneimiffel. 43 992-996 (1993).
29. A. A. Schreiber, K. Frei, W. Lichtensteiger and M. Schlumpf, Age. Act. 39 166-173 (1993).
30. A. Munk and A. Naray-Fejes-Toth, Ann. New York Acad. Sci. 746 115-130 (1994).
31. A. Kelso and A. Munck, J. Immunol. 133 784-791 (1984).
32. S. K. Arya, F. Wong-Staal and R. C. Gallo, J. Immunol. 133 273-276 (1984).
33. Y. Amano, S. W. Lee and A. C. Allison, Mol. Pharmacol. 43 176-182 (1993)
34. G. J. Wiegers and J. M. H. M. Reul, Tips 19 317-321 (1998).
35. F. Zavala, V. Taupin and B. J. Descamps-Latscha, J. Pharmacol. Exp. Ther. 255 442-449 (1990).
36. L. Isaac, Imunologia Básica, Calicjh, VLG, Vaz, CAC (Eds.), 42-50, Artes Médicas, São Paulo (1989).
37. I. Fidler, Cancer Res. 45 4714 (1985).
38. M. Papadimitrius and R. B. Ashman, Ultrst. Path. 13 343 (1989).
39. R. Keller, R. Keist and K. Frei, Eur. J. Immunol. 20 695 (1990).
40. F. Nathan, M. L. Karnovsky and J. R. David, J. Exptl. Med. 133 1356 (1971).
41. M. Lehn, W. Y. Weiser, S. Engelhorn, S. Gillis and H. G. Renold, J. Immunol. 143 3020-24 (1989).